GAPP is Back and Bigger than Ever!

Ten national and regional Ontario Genomics projects are part of $20 million funding package
Announcing: Ontario’s New GAPP Projects

Ten national and regional Ontario Genomics projects are part of $20 million funding package

Ten new Ontario Genomics projects are part of the Canadian government’s $20 million investment in 34 biotech R&D commercialization initiatives across the country.

Stemming from the Canadian Genomics Strategy, these national and regional Genomic Applications Partnership Program (GAPP) projects are advancing precision healthcare, cleantech and food safety in a variety of ways.

Here are the latest projects:

Neurodegenerative Disease Drug Development
– Janice Robertson, University of Toronto, Faculty of Medicine
– Marc Shenouda, Neuropeutics Inc.
– Funding: $882,188

Drug Distribution in Tissues
– Hartland Jackson, Sinai Health System (Mount Sinai Hospital)
– Funding: $745,119

Upcycling Food Waste into Chemical Ingredients
– Christopher Lawson, University of Toronto
– Connor Bowers, SymBL Innovations Inc.
– Funding: $705,156

Expanding Rare Disease Detection
– Bekim Sadikovic, London Health Sciences Centre Research Inc.
– Dan Sinai, Episign Inc.
– Funding: $691,146

Dairy Product Safety Testing
– Lawrence Goodridge, University of Guelph
– Anilda Guri, Gay Lea Foods Co-operative Limited
– Funding: $2,189,276

Breeding Climate-resilient Cattle
– Filippo Miglior, Lactanet
– Francesca Malchiodi, Semex Alliance
– Funding: $2,028,588

Bioremediation at Petroleum Sites
– Elizabeth Edwards, University of Toronto
– Rachel Peters, Federated Co-operatives Limited
– Funding: $900,034

AI-Guided Genome Editing Platform for Genetic Diseases
– David Edgell, The University of Western Ontario
– Brent Stead, Specific Biologics Inc.
– Funding: $1,874,621

Drug Delivery to the Central Nervous System
– Stephane Angers, University of Toronto
– Tracy Stone, ProteinQure
– Funding: $2,545,768

AI-assisted Genomic Test Software (Genome Atlantic & Ontario Genomics)
– Victor Martinez, IWK Health Centre
– Orion Buske, PhenoTips
– Funding: $5,428,690

“These projects move the science out of the lab and into real-world impact. With this investment, Ontario will advance earlier detection and better treatment for rare diseases and help bring precision medicines closer to patients. It will also back made-in-Ontario technologies that can clean up fuel spills with microbes, breed climate-resilient cattle and improve quality control in the dairy industry.”John Rafferty, Ontario Genomics President and CEO.

“Canada is in a race to turn scientific strength into economic leadership, and genomics is a field where we’re out in front. Combined with AI, it’s unlocking opportunities in agriculture, natural resources and health that simply didn’t exist five years ago. Through these projects and a growing focus on commercialization and adoption, Genome Canada is helping ensure Canada leads in the industries that will define the next decade.”Rob Annan, President and CEO, Genome Canada.

Related Articles